Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM
Trial details
- Registry ID
- NCT04848506
- Phase
- Phase 2, Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCMNCT04848506 | Cytokinetics | Phase 2, Phase 3 | Enrolling by invitation | 2029-03Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |